SEC Form 4/A · accession 0000899243-17-003639
Sorrento Therapeutics, Inc. · SRNE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Henry Ji
Officer — President and CEO · Director
Period of report
Feb 10, 2017
Accepted (ET)
Feb 10, 2017 · 7:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000850261
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 10, 2017 | P | 20,000 | $5.15 | A | 37,776 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This amended report on Form 4 is being filed to amend the Form 4 filed by the reporting person on February 3, 2017 to correct the transaction date, which was inadvertently reported as February 3, 2017.